Verition Fund Management’s Catalyst Pharmaceutical CPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $422K | Sell |
19,445
-9,866
| -34% | -$214K | ﹤0.01% | 2327 |
|
|
2025
Q1 | $711K | Sell |
29,311
-46,795
| -61% | -$1.13M | ﹤0.01% | 1796 |
|
|
2024
Q4 | $1.59M | Buy |
76,106
+8,604
| +13% | +$180K | 0.01% | 1287 |
|
|
2024
Q3 | $1.34M | Buy |
67,502
+43,447
| +181% | +$864K | 0.01% | 1166 |
|
|
2024
Q2 | $373K | Buy |
+24,055
| New | +$373K | ﹤0.01% | 1608 |
|
|
2022
Q4 | – | Sell |
-10,022
| Closed | -$129K | – | 1793 |
|
|
2022
Q3 | $129K | Buy |
+10,022
| New | +$129K | ﹤0.01% | 1981 |
|
|
2015
Q2 | – | Sell |
-23,050
| Closed | -$100K | – | 610 |
|
|
2015
Q1 | $100K | Buy |
+23,050
| New | +$100K | 0.01% | 323 |
|